Patent · US Active

Chemokine binding polypeptides for treating autoimmunity and inflammation

US9493557B2 · kind B2 · utility

7Cited by

1References

2Claims

0Family size

Assignee

Biokine Therapeutics Ltd. · IL

Inventors

Michal Abraham · Mevaseret Tsiyon, IL
Orly Eizenberg · Rehovot, IL
Amnon Peled · Tel Aviv-Yafo, IL

Key dates

Filing date	Feb 12, 2014
Grant date	Nov 15, 2016
Priority date	—
Expiry date	Feb 12, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel polypeptides comprising a chemokine-binding peptide and an Fc fragment are disclosed. The polypeptides are capable of binding to certain chemokines so as to modulate their activity. These polypeptides can be used to modulate in vivo chemokine-dependent processes such as inflammation and autoimmunity, and to treat associated conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.